Company intelligence / Profile preview

Brightflow Medical

Paris, Île-de-France, Francebrightflow.com ↗

Ownership: Private
Development stage: Other

Overview

Brightflow Medical has developed a minimally invasive, fully percutaneous implantable cardiac pump designed for long-term mechanical circulatory support of the right ventricle. The device aims to address severe and irreversible right-sided heart failure—a condition with high mortality and few treatment options. As of September 2024, the company has raised significant Series A funding (€16.5M) to complete product development and initiate first compassionate use implants by early 2026. No published clinical results yet.

Therapeutic areas: Cardiovascular
Modalities: Device (Implantable cardiac pump)Mechanical circulatory support system
Industry: Therapeutic Medical Devices

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Brightflow Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brightflow Medical.

Explore the full profile